Management of massive pulmonary embolism using recombinant activated Factor VII

被引:0
|
作者
Reyes, Guillermo [1 ]
Carrasco, Nieves [2 ]
Munoz, Teresa [2 ]
Duarte, Juan [1 ]
机构
[1] Hosp Univ La Princesa, Dept Cardiovasc Surg, Madrid 28006, Spain
[2] Hosp Univ La Princesa, Dept Intens Care Unit, Madrid 28006, Spain
关键词
pulmonary embolism; recombinant activated Factor VII; bleeding;
D O I
10.1016/j.ejcts.2008.03.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Massive pulmonary embolism with concomitant intracranial haemorrhage is a condition associated with high mortality. Emergency embolectomy is indicated in those cases in which medical treatment is not possible. The case of a 65-year-old woman with massive pulmonary embolism after cranial trauma with intracranial. haemorrhage and two cardiac arrests prior to surgery is described. The patient suffered a right ventricular failure requiring 6 h of extracorporeal. circulation. After surgery a bleeding disorder happened despite conventional treatment. The patient was transferred to the ICU with packing. Despite the recent thrombotic event recombinant activated Factor VII (70 mu g/kg) was used and the bleeding controlled. No other complications occurred and she was discharged 1 month later. As far as we know this is the first time that recombinant activated Factor VII has been used after a massive pulmonary embolism. (C) 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1144 / 1145
页数:2
相关论文
共 50 条
  • [31] Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage
    Heslet, Lars
    Nielsen, Jorn Dalsgaard
    Levi, Marcel
    Sengelov, Henrik
    Johansson, Paer I.
    CRITICAL CARE, 2006, 10 (06):
  • [32] Use of recombinant activated factor vII in bronchoalveolar lavage in a case of pulmonary hemorrhage
    Rodriguez-Serrano, D. A.
    Leal-Micharet, A.
    Rajas, O.
    Chicot-Llano, M.
    Garcia-Romero de Tejada, J. A.
    MEDICINA INTENSIVA, 2015, 39 (04) : 253 - 255
  • [33] Control of life-threatening pulmonary bleeding with activated recombinant factor VII
    Kamphusien, PW
    van den Akker, JM
    Kaasjager, KAH
    Bloemen, TIFM
    AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04): : 332 - 333
  • [34] Unprovoked Pulmonary Embolism in Factor VII Deficiency
    Singh, Balraj
    Modi, Varun
    Kaur, Parminder
    Guron, Gunwant
    Maroules, Michael
    ACTA HAEMATOLOGICA, 2020, 143 (02) : 181 - 183
  • [35] Management of Massive and Submassive Pulmonary Embolism
    Mehta, Nimeshkumar
    Sekhri, Vishal
    Lehrman, Stuart G.
    Aronow, Wilbert S.
    AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (06) : 664 - 675
  • [36] The use of recombinant activated factor VII in congenital and acquired factor VII deficiencies
    Muleo, G
    Santoro, R
    Iannaccaro, PG
    Papaleo, P
    Leo, F
    BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (04) : 389 - 390
  • [37] Recombinant activated factor VII in uncontrolled hemorrhage
    Colomina, ML
    Altisent, C
    Guerrero, E
    Godet, C
    MEDICINA CLINICA, 2005, 124 (04): : 156 - 156
  • [38] ST-Segment Elevation Myocardial Infarction (STEMI) and Pulmonary Embolism in a Hemophilia A Patient Receiving Emicizumab and recombinant Activated Factor VII
    Gundabolu, Krishna
    Goldsweig, Andrew
    Bhatt, Vijaya R.
    Koepsell, Scott A.
    Harper, James L.
    HAEMOPHILIA, 2020, 26 (01) : E5 - E8
  • [39] MASSIVE PULMONARY EMBOLISM - MEDICAL MANAGEMENT
    MILLER, GAH
    BRITISH MEDICAL JOURNAL, 1970, 2 (5712): : 777 - &
  • [40] DIAGNOSIS AND MANAGEMENT OF MASSIVE PULMONARY EMBOLISM
    DAICOFF, GR
    RANNIGER, K
    GREENBUR.AG
    RAMS, JJ
    MOULDER, PV
    CIRCULATION, 1965, 32 (4S2) : 73 - &